Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market – Forecast To 2024

Publishing Date : May, 2018
Report Code : HCMD0160
Price:
Single license $4,950
Site license $6,750
Global license $9,000


The Cardiac electrophysiology mapping, navigation and recording devices are used to assess the timing and propagation of cardiac electrical activity, which are obtained using multiple intravascular electrode catheters positioned at various locations within the heart. According to IQ4I analysis, the cardiac electrophysiology mapping, navigation and recording devices global market is expected to grow at mid single digit CAGR to reach $1,447.3 million by 2024. The cardiac EP mapping, navigation and recording devices market is mainly segmented by products, end-users and by geography. Cardiac EP mapping, navigation and recording devices by products is segmented into mapping and navigation systems, mapping catheters and navigation catheters, recording systems and accessories. Among the products, recording systems hold the highest share in 2017 and expected to grow at low single digit CAGR to reach $519.5 million by 2024. Mapping and Navigation Catheters segment is expected to grow at a high CAGR from 2017 to 2024. The mapping systems and navigation systems segment is further segmented by mapping system type as contact mapping systems and non contact mapping systems. The contact mapping segment holds the highest share of 70.5% in 2017 and expected to grow at mid single digit CAGR from 2017 to 2024.

End-Users of Cardiac EP mapping, navigation and recording devices are segmented into hospitals, cardiac & ambulatory surgical centres and academics & research institutes. The hospital segment commanded the largest revenue in 2017 and expected to grow at mid CAGR during the forecasting period. Cardiac & ambulatory surgical centres segment is expected to grow at a strong CAGR from 2017 to 2024.

The Cardiac EP mapping, navigation and recording devices global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue in 2017 and Asia-Pacific is expected to grow at highest CAGR during the forecasting period.

Some of the major players in Cardiac EP mapping, navigation and recording devices market include Abbott Laboratories (St Jude Medical) (U.S.), Boston Scientific (U.S.), Johnson & Johnson (Biosense Webster) (U.S.), Medtronic PLC. (Ireland), Stereotaxis, Inc. (U.S.), Acutus Medical (U.S.), GE Healthcare (U.S.), Auris Surgical Robotics (Hansen Medical), Microport Scientific Corporation (China), Magnetecs Corporation (U.S.).

 

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

o U.S.

o Others

• Europe

o Germany

o U.K.

o France

o Others

• Asia-Pacific

o Japan

o China

o India

o Others

• Rest of the World (RoW)

o Brazil

o Rest of Latin America

o Middle East & Others

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN NUMBER OF PATIENTS WITH ARRHYTHMIA
        • 3.3.1.2     EMERGING TECHNOLOGIES IN ELECTROPHYSIOLOGY
        • 3.3.1.3     RISING GERIATRIC POPULATION PRONE TO CHRONIC DISORDERS
        • 3.3.1.4     INCREASE IN RESEARCH AND DEVELOPMENT ACTIVITIES
        • 3.3.1.5     INCREASE IN MINIMALLY INVASIVE SURGERY FOR ATRIAL FIBRILLATION
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF THE DEVICES
        • 3.3.2.2     EXPOSURE TO RADIATION
        • 3.3.2.3     INACCURACY OF THE IMAGING SYSTEMS DUE TO BODY MOVEMENTS
        • 3.3.2.4     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.5     LACK OF SKILLED AND TRAINED PROFESSIONALS
        • 3.3.2.6     AVAILABILITY OF ALTERNATIVE PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
        • 3.4.1.3     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     JAPAN
      • 3.4.6     CHINA
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
    • 3.6     PATENT TRENDS
    • 3.7     TECHNOLOGICAL ADVANCEMENTS
      • 3.7.1     INTRODUCTION
      • 3.7.2     RHYTHMIA HDX MAPPING SYSTEM
      • 3.7.3     ENSITE PRESICION MAPPING SYSTEM
      • 3.7.4     ACQMAP HIGH RESOLUTION IMAGING AND MAPPING SYSTEM
    • 3.8     PORTER’S FIVE FORCE ANALYSIS
      • 3.8.1     THREAT OF NEW ENTRANTS
      • 3.8.2     THREAT OF SUBSTITUTES
      • 3.8.3     BARGAINING POWER OF SUPPLIERS
      • 3.8.4     BARGAINING POWER OF BUYERS
      • 3.8.5     COMPETITIVE RIVALRY
    • 3.9     SUPPLY CHAIN ANALYSIS
    • 3.10     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.10.1     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL
      • 3.10.2     MARKET SHARE ANALYSIS OF MAPPING AND NAVIGATION SYSTEMS
      • 3.10.3     MARKET SHARE ANALYSIS OF RECORDING SYSTEMS
    • 3.11     MARKET PENETRATION OF CARDIAC EP MAPPING CATHETER AND NAVIGATION CATHETER PROCEDURES IN GLOBAL CARDIAC ABLATION PROCEDURES AND GLOBAL CARDIAC SURGERIES
    • 3.12     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES NUMBER OF UNITS BY REGION
      • 3.12.1     MAPPING SYSTEMS AND NAVIGATION SYSTEMS NUMBER OF UNITS BY REGION
      • 3.12.2     RECORDING SYSTEMS NUMBER OF UNITS BY REGION
    • 3.13     MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL PROCEDURAL VOLUME, BY REGION
    • 3.14     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES COMPANY COMPARISON TABLE, BY PRODUCTS
  • 4     CARDIAC ELECTROPHYSIOLOGY (EP) MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     MAPPING SYSTEMS AND NAVIGATION SYSTEMS
      • 4.2.1     CONTACT MAPPING SYSTEMS
      • 4.2.2     NON CONTACT MAPPING SYSTEMS
    • 4.3     MAPPING CATHETERS AND NAVIGATION CATHETERS
    • 4.4     RECORDING SYSTEMS
    • 4.5     ACCESSORIES
  • 5     CARDIAC ELECTROPHYSIOLOGY (EP) MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET, BY END-USERS
    • 5.1     INTRODUCTION
    • 5.2     HOSPITALS
    • 5.3     CARDIAC CENTERS/AMBULATORY SURGICAL CENTERS
    • 5.4     OTHER END-USER
  • 6     REGIONAL ANALYSIS
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
      • 6.2.1     U.S.
      • 6.2.2     OTHERS
    • 6.3     EUROPE
      • 6.3.1     GERMANY
      • 6.3.2     U.K.
      • 6.3.3     FRANCE
      • 6.3.4     OTHERS
    • 6.4     APAC
      • 6.4.1     JAPAN
      • 6.4.2     CHINA
      • 6.4.3     INDIA
      • 6.4.4     OTHERS
    • 6.5     ROW
      • 6.5.1     BRAZIL
      • 6.5.2     REST OF LATAM
      • 6.5.3     MIDDLE EAST & OTHERS
  • 7     COMPETITIVE LANDSCAPE
    • 7.1     INTRODUCTION
    • 7.2     APPROVALS
    • 7.3     NEW PRODUCT LAUNCH
    • 7.4     ACQUISITIONS
    • 7.5     AGREEMENTS
  • 8     MAJOR COMPANIES
    • 8.1     ABBOTT LABORATORIES
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     ACUTUS MEDICAL
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     AURIS SURGICAL ROBOTICS (HANSEN MEDICAL)
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     BOSTON SCIENTIFIC CORPOARTION
      • 8.4.1     OVERVIEW
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     GE HEALTHCARE (GENERAL ELECTRIC COMPANY)
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     BUSINESS STRATEGY
    • 8.6     JOHNSON & JOHNSON (BIOSENSE WEBSTER)
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     MAGNETECS CORPORTION
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     MEDTRONIC, PLC
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     MICROPORT SCEINTIFIC CORPORTION
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.10     STEREOTAXIS, INC.
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 2     MAPPING SYSTEMS AND NAVIGATION SYSTEMS NUMBER OF UNITS, BY REGION (2016-2024) (NO’S)
      • TABLE 3     RECORDING SYSTEMS NUMBER OF UNITS, BY REGION (2016-2024) (NO’S)
      • TABLE 4     MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL PROCEDURAL VOLUME, BY REGION (2016-2024) (NO’S)
      • TABLE 5     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 6     MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 7     MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 8     CONTACT MAPPING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 9     NON CONTACT MAPPING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 10     MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 11     RECORDING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 12     ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 13     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 14     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 15     CARDIAC CENTERS/AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 16     OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 17     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 18     NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 19     NORTH AMERICA MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 20     NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 21     NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 22     EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 23     EUROPE MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 24     EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 25     EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 26     APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 27     APAC MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 28     APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 29     APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 30     ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 31     ROW MAPPING SYSTEMS AND NAVIGATION SYSTEMS MARKET REVENUE, BY PRODUCT TYPE, (2016-2024) ($MN)
      • TABLE 32     ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 33     ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 34     APPROVALS (2016 - 2018)
      • TABLE 35     NEW PRODUCT LAUNCH (2016 - 2018)
      • TABLE 36     ACQUISITIONS (2016 - 2018)
      • TABLE 37     AGREEMENTS (2016 - 2018)
      • TABLE 38     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 39     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 40     ABBOTT LABORATORIES: CARDIOVASCULAR AND NEUROMODULATION SEGMENTS REVENUE (2015-2017) ($MN)
      • TABLE 41     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 42     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 43     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 44     BOSTON SCIENTIFIC CORPORATION:RHYTHM MANAGEMENT, BY SEGMNETS, (2015-2017) ($MN)
      • TABLE 45     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 46     GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 47     GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
      • TABLE 48     GE HEALTHCARE: REVENUE, BY HEALTH CARE SUB- SEGMENTS (2015-2017) ($MN)
      • TABLE 49     GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 50     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 51     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 52     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 53     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 54     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 55     MEDTRONIC, PLC: CARDIAC & VASCULAR TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
      • TABLE 56     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 57     MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 58     MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 59     MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 60     STEREOTAXIS, INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 61     STEREOTAXIS, INC.: TOTAL REVENUE BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 62     STEREOTAXIS, INC.: TOTAL REVENUE BY GEOGRAPHY, (2015-2017) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET
      • FIGURE 3     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CARDIAC ELECTROPHYSIOLOGY MAPPING AND RECORDING DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2017)
      • FIGURE 9     CARDIAC ELECTROPHYSIOLOGY NAVIGATION DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2017)
      • FIGURE 10     CARDIAC ELECTROPHYSIOLOGY MAPPING, NAVIGATION AND RECORDING DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 11     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 12     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 13     CARDIAC ELECTROPHYSIOLOGY MAPPING AND NAVIGATION SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 14     CARDIAC ELECTROPHYSIOLOGY RECORDING SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 15     CARDIAC EP MAPPING CATHETER AND NAVIGATION CATHETER PROCEDURES GLOBAL MARKET PENETRATION, (2017) (NO’S)
      • FIGURE 16     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) (%)
      • FIGURE 17     MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2017) ($MN)
      • FIGURE 18     MAPPING SYSTEMS AND NAVIGATION SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 19     CONTACT MAPPING SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 20     NON CONTACT MAPPING SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 21     MAPPING CATHETERS AND NAVIGATION CATHETERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 22     RECORDING SYSTEMS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 23     ACCESSORIES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 24     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) (%)
      • FIGURE 25     HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 26     CARDIAC CENTERS/AMBULATORY SURGERY CENTERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 27     OTHER END-USERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 28     CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%)
      • FIGURE 29     NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
      • FIGURE 30     NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 31     U.S. CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 32     OTHER NORTH AMERICA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 33     EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
      • FIGURE 34     EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 35     GERMANY CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 36     U.K. CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 37     FRANCE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 38     OTHER EUROPE CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 39     APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
      • FIGURE 40     APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 41     JAPAN CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 42     CHINA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 43     INDIA CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 44     OTHER APAC CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 45     ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) (%)
      • FIGURE 46     ROW CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES REVENUE, BY COUNTRY (2017 V/S 2024) (%)
      • FIGURE 47     BRAZIL CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 48     REST OF LATAM CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 49     MIDDLE EAST & OTHERS CARDIAC EP MAPPING, NAVIGATION AND RECORDING DEVICES MARKET SHARE, BY PRODUCT AND END-USERS (2017 V/S 2024) ($MN)
      • FIGURE 50     KEY GROWTH STRATEGIES, (2016-2018)
      • FIGURE 51     SWOT: ABBOTT LABORATORIES
      • FIGURE 52     SWOT: ACUTUS MEDICAL
      • FIGURE 53     SWOT: AURIS SURGICAL ROBOTICS (HANSEN MEDICAL)
      • FIGURE 54     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 55     SWOT: GE HEALTHCARE
      • FIGURE 56     SWOT: BIOSENSE WEBSTER
      • FIGURE 57     SWOT: MAGNETECS CORPORATION
      • FIGURE 58     SWOT: MEDTRONIC, PLC
      • FIGURE 59     SWOT: MICROPORT SCIENTIFIC CORPORATION (HANSEN MEDICAL)
      • FIGURE 60     SWOT: STEREOTAXIS, INC.